| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |